Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Specialized transfusion support for solid organ transplantation.

Darrell J Triulzi1

  • 1Department of Pathology, University of Pittsburgh, Pennsylvania, USA. dtriulzi@itxm.org

Current Opinion in Hematology
|October 24, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world use of pharmacologic therapy and chronic blood transfusion in sickle cell disease, 2014-2021.

Annals of hematology·2026
Same author

Prophylactic high-dose granulocyte transfusions following allogeneic haematopoietic stem cell transplantation.

Vox sanguinis·2025
Same author

The wider perspective: Barriers and recommendations for transfusion support for patients with sickle cell disease in low- and middle-income countries.

British journal of haematology·2025
Same author

Restrictive versus Liberal Transfusion in Myocardial Infarction - A Patient-Level Meta-Analysis.

NEJM evidence·2024
Same author

Impact of variable titer COVID-19 convalescent plasma and recipient SARS-CoV2-specific humoral immunity on survival in hospitalized patients.

PloS one·2024
Same author

Analysis of bleeding outcomes in patients with hypoproliferative thrombocytopenia in the A-TREAT clinical trial.

Transfusion·2024
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Solid organ transplant recipients require specialized transfusion support due to unique risks. Transfusion specialists must manage complications like infections and graft rejection in these immunocompromised patients.

Area of Science:

  • Transfusion Medicine
  • Immunology
  • Transplantation

Background:

  • Solid organ transplantation is increasing in complexity and frequency.
  • Transplant recipients present unique transfusion challenges, including product availability, serologic issues, and immunologic effects.
  • Immunosuppressive agents used in transplant recipients increase susceptibility to transfusion complications.

Purpose of the Study:

  • To highlight the specialized needs of transfusion services for solid organ transplant recipients.
  • To discuss the immunologic and infectious risks associated with transfusion in this population.
  • To emphasize the role of transfusion specialists in mitigating transfusion-related complications.

Main Methods:

  • Review of current literature on transfusion practices in solid organ transplantation.

Related Experiment Videos

  • Analysis of immunologic and infectious complications associated with transfusion in transplant recipients.
  • Discussion of strategies for risk reduction and optimal transfusion management.

    • Main Results:

    • Transplant recipients are at higher risk for cytomegalovirus infection and transfusion-associated graft-versus-host disease due to immunosuppression.
    • Alloimmunization following transfusion can lead to severe graft rejection, both acute and chronic.
    • Specialized blood components and careful serologic evaluation are crucial.

    Conclusions:

    • Transfusion management in solid organ transplant recipients requires a multidisciplinary approach.
    • Proactive strategies are essential to minimize transfusion risks, including infection and graft rejection.
    • Transfusion specialists play a critical role in ensuring safe and effective transfusion support for transplant patients.